People · Operator
Named in public records as an officer, director or promoter · active 2018–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sana Biotechnology, Inc. | — | Biotechnology | Growth/Late | $866.9M | $34.8B | 2018 |
Steven D. Harr at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven D. Harr on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| STEPHEN J. KNIGHT | 1 | 3 |
| Douglas J. Cole | 1 | 2 |
| Robert J. Nelsen | 1 | 2 |
| Richard J. Mulligan | 1 | 1 |
| Patrick J. Yang | 1 | 1 |
| James J. MacDonald | 1 | 1 |
| Nathan D. Hardy | 1 | 1 |
| Mary Agnes J. Wilderotter | 1 | 1 |
| Hans J. Bishop | 1 | 1 |
| Geoffrey J. Von Maltzahn | 1 | 1 |
| Donald J. Payan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.